New iron nanomaterial wipes out cancer cells without harming healthy tissue
Comments
Science News
from research organizations
New iron nanomaterial wipes out cancer cells without harming healthy tissue
Date:
March 1, 2026
Source:
Oregon State University
Summary:
Scientists at Oregon State University have engineered a powerful new nanomaterial that zeroes in on cancer cells and destroys them from the inside out. Designed to exploit cancer’s unique chemistry—its acidity and high hydrogen peroxide levels—the tiny iron-based structure sparks not one but two intense chemical reactions, flooding tumors with cell-damaging oxygen molecules. This dual attack overwhelms cancer cells with oxidative stress while sparing healthy tissue.
Share:
FULL STORY
[New Iron Nanomaterial Wipes Out Cancer]
*A new iron-based nanotherapy destroys cancer cells by unleashing a double burst of toxic oxygen reactions inside tumors. In mice, it completely eliminated breast cancer without harming healthy tissue or causing side effects. Credit: Shutterstock*
Researchers at Oregon State University have created a new nanomaterial designed to destroy cancer cells from the inside. The material activates two separate chemical reactions once inside a tumor cell, overwhelming it with oxidative stress while leaving surrounding healthy tissue unharmed.
The work, led by Oleh Taratula, Olena Taratula, and Chao Wang from the OSU College of Pharmacy, was published in Advanced Functional Materials.
Advancing Chemodynamic Therapy
The discovery strengthens the growing field of chemodynamic therapy or CDT. This emerging cancer treatment strategy takes advantage of the unique chemical conditions found inside tumors. Compared with normal tissue, cancer cells tend to be more acidic and contain higher levels of hydrogen peroxide.
Traditional CDT uses these tumor conditions to spark the formation of hydroxyl radicals, highly reactive molecules made of oxygen and hydrogen that contain an unpaired electron. These reactive oxygen species damage cells through oxidation, stripping electrons from essential components such as lipids, proteins, and DNA.
More recent CDT approaches have also succeeded in generating singlet oxygen inside tumors. Singlet oxygen is another reactive oxygen species, named for its single electron spin state rather than the three spin states seen in the more stable oxygen molecules present in the air.
Overcoming Limits of Existing CDT Agents
"However, existing CDT agents are limited," Oleh Taratula said. "They efficiently generate either radical hydroxyls or singlet oxygen but not both, and they often lack sufficient catalytic activity to sustain robust reactive oxygen species production. Consequently, preclinical studies often only show partial tumor regression and not a durable therapeutic benefit."
To address these shortcomings, the team developed a new CDT nanoagent built from an iron-based metal-organic framework or MOF. This structure is capable of producing both hydroxyl radicals and singlet oxygen, increasing its cancer-fighting potential. The MOF demonstrated strong toxicity across multiple cancer cell lines while causing minimal harm to noncancerous cells.
Complete Tumor Regression in Mice
"When we systemically administered our nanoagent in mice bearing human breast cancer cells, it efficiently accumulated in tumors, robustly generated reactive oxygen species and completely eradicated the cancer without adverse effects," Olena Taratula said. "We saw total tumor regression and long-term prevention of recurrence, all without seeing any systemic toxicity."
In these preclinical experiments, tumors disappeared entirely and did not return, and the animals showed no signs of harmful side effects.
Next Steps Toward Broader Cancer Treatment
Before moving into human trials, the researchers plan to test the treatment in additional cancer types, including aggressive pancreatic cancer, to determine whether the approach can be effective across a wide range of tumors.
Other contributors to the study included Oregon State researchers Kongbrailatpam Shitaljit Sharma, Yoon Tae Goo, Vladislav Grigoriev, Constanze Raitmayr, Ana Paula Mesquita Souza, and Manali Parag Phawde. Funding was provided by the National Cancer Institute of the National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
RELATED TOPICS
Health & Medicine
**Breast Cancer
**Pancreatic Cancer
**Personalized Medicine
**Workplace Health
**Genes
**Cancer
**Women's Health
**Diseases and Conditions
RELATED TERMS
**Cancer
**Monoclonal antibody therapy
**Adult stem cell
**Embryonic stem cell
**Heart
**Gene therapy
**Natural killer cell
**Panic attack
Story Source:
Materials provided by Oregon State University. Note: Content may be edited for style and length.
Journal Reference:
- Chao Wang, Kongbrailatpam Shitaljit Sharma, Yoon Tae Goo, Vladislav Grigoriev, Constanze Raitmayr, Ana Paula Mesquita Souza, Manali Parag Phawde, Olena R. Taratula, Oleh Taratula. Structurally Engineered Ferrous Metal–Organic Framework as a Chemodynamic Therapy Nanoagent for Concurrent Hydroxyl Radical and Singlet Oxygen Generation. Advanced Functional Materials, 2026; DOI: 10.1002/adfm.202529194
Cite This Page:
- MLA
- APA
- Chicago
Oregon State University. "New iron nanomaterial wipes out cancer cells without harming healthy tissue." ScienceDaily. ScienceDaily, 1 March 2026. <www.sciencedaily.com/releases/2026/02/260228093456.htm>.
Oregon State University. (2026, March 1). New iron nanomaterial wipes out cancer cells without harming healthy tissue. ScienceDaily. Retrieved March 1, 2026 from www.sciencedaily.com/releases/2026/02/260228093456.htm
Oregon State University. "New iron nanomaterial wipes out cancer cells without harming healthy tissue." ScienceDaily. www.sciencedaily.com/releases/2026/02/260228093456.htm (accessed March 1, 2026).
Explore More
from ScienceDaily
June 20, 2025 USC researchers have uncovered a hidden driver behind the early and severe onset of Alzheimer's in people with Down syndrome: iron overload in the brain. Their study revealed that individuals ...
A New Class of Molecules Against Cancer Cells Refractory to Standard Treatments
May 7, 2025 A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...
Chemists Unlock the Potential of Ketone and Ester Molecules, Paving the Way for Greener and More Efficient Drug Development
Jan. 9, 2025 Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with an alcohol) to be locked treasure chests of possibilities. Ubiquitous as ...
Fine Particulate Matter Catalyzes Oxidative Stress in the Lungs
May 22, 2023 Study sheds new light on the adverse health effects of air pollution: hydrogen peroxide production of fine particles may not be as important as previously assumed. A new study reveals that the ...
One in Two Pregnancies Are Affected by Iron Deficiency, Yet Many Women Don’t Get a Simple Screening Test to Check
Aug. 30, 2021 Half of pregnant women who had a simple blood test to check their iron stores had low iron levels, and one in four had severe iron deficiency, according to a new article. But despite how common iron ...
New Strategy for Drug Design: Keeping Copper Atoms Closer to Keep Bacteria Away
July 27, 2021 Hydrogen peroxide reacts with copper to produce hydroxyl radicals with strong antibacterial properties. However, this requires high copper concentrations because two copper atoms have to come close ...
[...]